Major adverse events during the first 30 days after stent placement according to the Br genotype
| . | a/a (n = 13) . | a/b (n = 327) . | b/b (n = 1457) . | P . |
|---|---|---|---|---|
| Death | 0 | 0 | 9 (0.6) | .35 |
| Myocardial infarction | 0 | 17 (5.2) | 64 (4.4) | .60 |
| Q wave | 0 | 2 (0.6) | 22 (1.5) | .40 |
| Non-Q wave | 0 | 15 (4.6) | 42 (2.9) | .23 |
| Urgent revascularization | 0 | 8 (2.5) | 40 (2.8) | .80 |
| Any of the above events | 0 | 21 (6.4) | 88 (6.0) | .63 |
| . | a/a (n = 13) . | a/b (n = 327) . | b/b (n = 1457) . | P . |
|---|---|---|---|---|
| Death | 0 | 0 | 9 (0.6) | .35 |
| Myocardial infarction | 0 | 17 (5.2) | 64 (4.4) | .60 |
| Q wave | 0 | 2 (0.6) | 22 (1.5) | .40 |
| Non-Q wave | 0 | 15 (4.6) | 42 (2.9) | .23 |
| Urgent revascularization | 0 | 8 (2.5) | 40 (2.8) | .80 |
| Any of the above events | 0 | 21 (6.4) | 88 (6.0) | .63 |
Numbers in parentheses are percentages.